Skip to main content
Medical information Clinical review pending

Genetic Testing

GYG2 Gene Autism GYG2 Related Genetic Test

The GYG2 Gene Autism Genetic Test uses Next Generation Sequencing (NGS) to identify genetic variations in the GYG2 gene associated with autism spectrum disorders. This test can provide valuable insights for families seeking to understand genetic factors related to autism.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (EDTA tube), Extracted DNA, or One drop of blood on an FTA card.
Results
Confirm with the laboratory before booking.
Preparation
No specific fasting is required. Confirm with the laboratory before booking regarding specific sample collection procedures and any necessary pre-test counseling.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the GYG2 Gene Autism GYG2 Related Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Individuals with a personal or family history of autism spectrum disorders.
  • ✓Individuals exhibiting developmental delays or neurological symptoms suggestive of autism.
  • ✓Families seeking genetic information to understand potential causes of autism.
  • ✓Assisting in the diagnosis of autism spectrum disorders.
  • ✓Genetic counseling for families with a history of autism.
02

In plain language

What this test helps you understand

This test identifies genetic variations in the GYG2 gene, which may be associated with autism spectrum disorders. It can help provide genetic information relevant to an individual's condition and family history.
The GYG2 Gene Autism Genetic Test is a diagnostic tool designed to explore the genetic factors linked to autism spectrum disorders. It utilizes advanced Next Generation Sequencing (NGS) technology to analyze the GYG2 gene. Understanding genetic contributions can be helpful for families affected by autism. This test aims to identify specific genetic variations within the GYG2 gene that have been associated with autism spectrum disorders. By analyzing these markers, healthcare providers may gain a clearer understanding of potential genetic influences. This information can support clinical evaluation and potentially guide management strategies. Discuss the relevance of this test with your doctor.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific fasting is required. Confirm with the laboratory before booking regarding specific sample collection procedures and any necessary pre-test counseling.
SampleBlood sample (EDTA tube), Extracted DNA, or One drop of blood on an FTA card.
MethodologyNext Generation Sequencing (NGS) is used to analyze the GYG2 gene for specific genetic variations.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test analyzes only the GYG2 gene. Autism spectrum disorders can be caused by variations in many different genes or environmental factors. A negative result does not rule out autism or other genetic conditions. Results should be interpreted by a qualified healthcare professional.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

The GYG2 gene provides instructions for making a protein involved in brain development and function. Variations in this gene have been linked to autism spectrum disorders.
Individuals with a personal or family history of autism, or those showing developmental delays, may be candidates for this test. Discuss with your doctor.
This test specifically looks for genetic variations within the GYG2 gene that are associated with autism spectrum disorders.
Results should be interpreted by a qualified healthcare professional, often in consultation with a genetic counselor, considering clinical information and family history.
A blood sample, extracted DNA, or a single drop of blood on an FTA card is required for testing.
Yes, scheduling a genetic counseling session before testing is recommended to discuss family history and the implications of the test.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp